$UBX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Unity Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Unity Biotechnology, Inc.. Get notifications about new insider transactions in Unity Biotechnology, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UBX | Unity Biotechnolog ... | COOPER GRAHAM K | Director | Option Exercise | A | 4.18 | 25,000 | 104,500 | 25,000 | |
| Jun 28 2021 | UBX | Unity Biotechnolog ... | Leonard Keith R | Director | Option Exercise | A | 4.18 | 25,000 | 104,500 | 25,000 | |
| Jun 28 2021 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 4.18 | 25,000 | 104,500 | 25,000 | |
| Jun 28 2021 | UBX | Unity Biotechnolog ... | O'Neill Gilmore Neil | Director | Option Exercise | A | 4.18 | 13,425 | 56,117 | 13,425 | |
| Jun 23 2021 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Payment of Exercise | F | 4.18 | 3,515 | 14,693 | 685,875 | 689.4 K to 685.9 K (-0.51 %) |
| Apr 01 2021 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Payment of Exercise | F | 5.73 | 2,829 | 16,210 | 689,390 | 692.2 K to 689.4 K (-0.41 %) |
| Mar 11 2021 | UBX | Unity Biotechnolog ... | Nguyen Alexander Hieu | See Remarks | Option Exercise | A | 6.69 | 250,000 | 1,672,500 | 250,000 | |
| Feb 02 2021 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Option Exercise | A | 5.98 | 150,000 | 897,000 | 150,000 | |
| Feb 02 2021 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 250,000 | 0 | 850,000 | 600 K to 850 K (+41.67 %) |
| Dec 18 2020 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Sell | S | 5.24 | 1,700,000 | 8,908,000 | 624,703 | 2.3 M to 624.7 K (-73.13 %) |
| Dec 14 2020 | UBX | Unity Biotechnolog ... | O'Neill Gilmore Neil | Director | Option Exercise | A | 6.12 | 50,000 | 306,000 | 50,000 | |
| Sep 15 2020 | UBX | Unity Biotechnolog ... | Sullivan Lynne Marie | Chief Financial Off ... | Grant | A | 0.00 | 240,000 | 0 | 240,000 | 0 to 240 K |
| Sep 15 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Option Exercise | A | 2.94 | 250,000 | 735,000 | 250,000 | |
| Sep 15 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 300,000 | 0 | 600,000 | 300 K to 600 K (+100.00 %) |
| Sep 15 2020 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Grant | A | 0.00 | 240,000 | 0 | 692,219 | 452.2 K to 692.2 K (+53.07 %) |
| Sep 15 2020 | UBX | Unity Biotechnolog ... | Azoy Alexander | See Remarks | Grant | A | 0.00 | 135,000 | 0 | 135,000 | 0 to 135 K |
| Aug 04 2020 | UBX | Unity Biotechnolog ... | Sullivan Lynne Marie | See Remarks | Option Exercise | A | 9.96 | 240,000 | 2,390,400 | 240,000 | |
| Jun 24 2020 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Payment of Exercise | F | 9.67 | 2,483 | 24,011 | 161,027 | 163.5 K to 161 K (-1.52 %) |
| Jun 24 2020 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Payment of Exercise | F | 9.67 | 2,483 | 24,011 | 2,324,703 | 2.3 M to 2.3 M (-0.11 %) |
| Jun 24 2020 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Payment of Exercise | F | 9.67 | 2,483 | 24,011 | 380,690 | 383.2 K to 380.7 K (-0.65 %) |
| Jun 24 2020 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Payment of Exercise | F | 9.67 | 2,483 | 24,011 | 452,219 | 454.7 K to 452.2 K (-0.55 %) |
| Jun 24 2020 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Payment of Exercise | F | 9.67 | 2,483 | 24,011 | 42,847 | 45.3 K to 42.8 K (-5.48 %) |
| Jun 24 2020 | UBX | Unity Biotechnolog ... | Leonard Keith R | Director | Payment of Exercise | F | 9.67 | 4,711 | 45,555 | 89,546 | 94.3 K to 89.5 K (-5.00 %) |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | Samuels Camille D | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | Lacey David L. | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | Roberts Margo R | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | COOPER GRAHAM K | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | Leonard Keith R | Director | Option Exercise | A | 9.14 | 50,000 | 457,000 | 50,000 | |
| Jun 09 2020 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Buy | P | 8.90 | 3,200 | 28,478 | 2,327,186 | 2.3 M to 2.3 M (+0.14 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Option Exercise | A | 5.95 | 800,000 | 4,760,000 | 800,000 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 150,000 | 0 | 300,000 | 150 K to 300 K (+100.00 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 120,000 | 0 | 150,000 | 30 K to 150 K (+400.00 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Grant | A | 0.00 | 24,255 | 0 | 45,330 | 21.1 K to 45.3 K (+115.09 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | A | 5.95 | 118,188 | 703,219 | 118,188 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Grant | A | 0.00 | 29,106 | 0 | 163,510 | 134.4 K to 163.5 K (+21.66 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Grant | A | 0.00 | 24,255 | 0 | 2,323,986 | 2.3 M to 2.3 M (+1.05 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Grant | A | 0.00 | 24,255 | 0 | 381,297 | 357 K to 381.3 K (+6.79 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Grant | A | 0.00 | 24,255 | 0 | 454,702 | 430.4 K to 454.7 K (+5.63 %) |
| Feb 26 2020 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | M | 3.43 | 10,000 | 34,300 | 110,620 | |
| Feb 26 2020 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Buy | M | 3.43 | 10,000 | 34,300 | 134,404 | 124.4 K to 134.4 K (+8.04 %) |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | A | 3.43 | 28,814 | 98,832 | 28,814 | |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | A | 3.43 | 35,525 | 121,851 | 35,525 | |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | A | 3.43 | 27,825 | 95,440 | 27,825 | |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Option Exercise | A | 3.40 | 19,068 | 64,831 | 19,068 | |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | A | 3.43 | 28,814 | 98,832 | 28,814 | |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | A | 3.43 | 35,525 | 121,851 | 35,525 | |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | A | 3.43 | 27,825 | 95,440 | 27,825 | |
| Sep 23 2019 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Option Exercise | A | 3.40 | 19,068 | 64,831 | 19,068 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Option Exercise | A | 9.00 | 106,800 | 961,200 | 106,800 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Grant | A | 0.00 | 21,075 | 0 | 21,075 | 0 to 21.1 K |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Option Exercise | A | 9.00 | 106,800 | 961,200 | 106,800 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Grant | A | 0.00 | 21,075 | 0 | 357,041 | 336 K to 357 K (+6.27 %) |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Option Exercise | A | 9.00 | 106,800 | 961,200 | 106,800 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Grant | A | 0.00 | 21,075 | 0 | 430,447 | 409.4 K to 430.4 K (+5.15 %) |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | A | 9.00 | 116,850 | 1,051,650 | 116,850 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Grant | A | 0.00 | 21,075 | 0 | 124,404 | 103.3 K to 124.4 K (+20.40 %) |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | A | 9.00 | 106,800 | 961,200 | 106,800 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Grant | A | 0.00 | 21,075 | 0 | 2,299,731 | 2.3 M to 2.3 M (+0.92 %) |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | A | 9.00 | 260,000 | 2,340,000 | 260,000 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Grant | A | 0.00 | 40,000 | 0 | 210,782 | 170.8 K to 210.8 K (+23.42 %) |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Samuels Camille D | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Roberts Margo R | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | Lacey David L. | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | COOPER GRAHAM K | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Jun 19 2019 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | M | 3.40 | 20,000 | 68,000 | 1,364,100 | |
| Jun 19 2019 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Buy | M | 3.40 | 20,000 | 68,000 | 170,782 | 150.8 K to 170.8 K (+13.26 %) |
| Dec 04 2018 | UBX | Unity Biotechnolog ... | Roberts Margo R | Director | Option Exercise | A | 13.67 | 50,661 | 692,536 | 50,661 | |
| Oct 12 2018 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | M | 3.43 | 5,000 | 17,150 | 120,620 | |
| Oct 12 2018 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Buy | M | 3.43 | 5,000 | 17,150 | 101,348 | 96.3 K to 101.3 K (+5.19 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 195,672 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,486,745 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,067,160 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 4,228,432 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,030,625 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 195,672 | 0 | 1,682,417 | 1.5 M to 1.7 M (+13.16 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,486,745 | 0 | 1,486,745 | 0 to 1.5 M |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,067,160 | 0 | 8,365,764 | 6.3 M to 8.4 M (+32.82 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 4,228,432 | 0 | 6,298,604 | 2.1 M to 6.3 M (+204.26 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,030,625 | 0 | 2,070,172 | 39.5 K to 2.1 M (+5,134.71 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | C | 0.00 | 1,630 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Buy | C | 0.00 | 1,630 | 0 | 96,348 | 94.7 K to 96.3 K (+1.72 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | C | 0.00 | 3,261 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Buy | C | 0.00 | 3,261 | 0 | 3,261 | 0 to 3.3 K |
| May 07 2018 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | C | 0.00 | 1,630 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | C | 0.00 | 222,148 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | C | 0.00 | 1,074,032 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Buy | C | 0.00 | 1,630 | 0 | 2,278,656 | 2.3 M to 2.3 M (+0.07 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Buy | C | 0.00 | 222,148 | 0 | 2,277,026 | 2.1 M to 2.3 M (+10.81 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Buy | C | 0.00 | 1,074,032 | 0 | 2,054,878 | 980.8 K to 2.1 M (+109.50 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 195,672 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 1,486,745 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 2,067,160 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 4,228,432 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 2,030,625 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Buy | C | 0.00 | 195,672 | 0 | 1,682,417 | 1.5 M to 1.7 M (+13.16 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Buy | C | 0.00 | 1,486,745 | 0 | 1,486,745 | 0 to 1.5 M |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Buy | C | 0.00 | 2,067,160 | 0 | 8,365,764 | 6.3 M to 8.4 M (+32.82 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Buy | C | 0.00 | 4,228,432 | 0 | 6,298,604 | 2.1 M to 6.3 M (+204.26 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Buy | C | 0.00 | 2,030,625 | 0 | 2,070,172 | 39.5 K to 2.1 M (+5,134.71 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,630 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | C | 0.00 | 148,448 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | C | 0.00 | 383,475 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Buy | C | 0.00 | 1,630 | 0 | 150,782 | 149.2 K to 150.8 K (+1.09 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Buy | C | 0.00 | 148,448 | 0 | 148,448 | 0 to 148.4 K |
| May 07 2018 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Buy | C | 0.00 | 383,475 | 0 | 383,475 | 0 to 383.5 K |
| May 07 2018 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Option Exercise | C | 0.00 | 1,630 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Option Exercise | C | 0.00 | 74,048 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Buy | C | 0.00 | 1,630 | 0 | 409,372 | 407.7 K to 409.4 K (+0.40 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Buy | C | 0.00 | 74,048 | 0 | 407,742 | 333.7 K to 407.7 K (+22.19 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Option Exercise | C | 0.00 | 195,672 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,486,745 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,067,160 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Option Exercise | C | 0.00 | 4,228,432 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,030,625 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Buy | C | 0.00 | 195,672 | 0 | 1,682,417 | 1.5 M to 1.7 M (+13.16 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Buy | C | 0.00 | 1,486,745 | 0 | 1,486,745 | 0 to 1.5 M |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Buy | C | 0.00 | 2,067,160 | 0 | 8,365,764 | 6.3 M to 8.4 M (+32.82 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Buy | C | 0.00 | 4,228,432 | 0 | 6,298,604 | 2.1 M to 6.3 M (+204.26 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | ARCH Venture Partners VII, LLC | 10% Owner | Buy | C | 0.00 | 2,030,625 | 0 | 2,070,172 | 39.5 K to 2.1 M (+5,134.71 %) |
| May 04 2018 | UBX | Unity Biotechnolog ... | Tompkins Tamara | Corporate Secretary ... | Option Exercise | A | 17.00 | 30,508 | 518,636 | 30,508 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | A | 17.00 | 40,678 | 691,526 | 40,678 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | A | 17.00 | 30,508 | 518,636 | 30,508 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | A | 17.00 | 47,458 | 806,786 | 47,458 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | Burow Kristina | Director | Option Exercise | A | 17.00 | 40,678 | 691,526 | 40,678 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | Leonard Keith R | Chief Executive Off ... | Option Exercise | A | 17.00 | 67,797 | 1,152,549 | 67,797 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Option Exercise | A | 17.00 | 30,508 | 518,636 | 30,508 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | COOPER GRAHAM K | Director | Option Exercise | A | 17.00 | 10,169 | 172,873 | 10,169 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Option Exercise | A | 17.00 | 30,508 | 518,636 | 30,508 | |
| May 04 2018 | UBX | Unity Biotechnolog ... | Samuels Camille D | Director | Option Exercise | A | 17.00 | 40,678 | 691,526 | 40,678 |
Page: 1